decisionhealth Newsletters, Coder Pink Sheets - 2011 Issue 9 (September)
Urology RoundUp: Coding the new Provenge® benefit
Subscribe or sign in to view the full article.
Article Overview
This article explains a Medicare reimbursement update tied to Provenge® (sipuleucel-T) and the associated national coverage policy. It is aimed at urology, oncology, and medical coding professionals who need to understand the coverage context, the relevant diagnosis-code requirements, and how contractor-level policies may affect billing. The piece also points to official CMS resources for further reference.
Why This Topic Matters
The article matters because it summarizes a new Medicare-covered therapy and the billing framework surrounding it, which can affect claim acceptance and contractor policy compliance. It helps readers identify the scope of coverage and the documentation/coding context they need to review before submitting claims.
What You Will Learn
- The Medicare coverage context for Provenge® and why the update matters to billing
- How the article frames the related HCPCS reporting and diagnosis-code requirements
- What role contractor implementation timing and local coverage discretion play in the policy
- Which official CMS resources are cited for follow-up
Who Should Read This
- Urology coders
- Oncology coders
- Billing staff
- Revenue cycle teams
- Practice managers
- Compliance staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com